United Kingdom

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.

We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

GSKH team member sitting at the desk

Currently, we invest around £1bn in research and development (R&D) in the UK annually with our global R&D hub at Stevenage continuing to be at the heart of the development of our pipeline of vital medicines, with a focus on the immune system, genetics, and advanced technologies.

Our culture powers our purpose, drives delivery of our strategy and helps make GSK a place where people can thrive. We are recognised in the Stonewall LGBT+ rights group as a top global employer and ranked in the Times Top 50 employers for women in the UK.

We also support our global and local communities. £1.7m has been raised by UK employees for Save the Children so far, with 100% of these funds being used to help provide UK families living on low incomes with essential household items, learning resources, and support that gives parents the skills, confidence and tools to help their children thrive.

Members of the public in the UK can obtain information about our products and areas of therapy by visiting our

GSK UK product website

Our locations in the UK

Contact details

GSK House
980Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom

General enquiries

UK Corporate 
Tel: +44 (0)20 8047 5000

UK Commercial 
Tel: +44 (0)20 8990 9000

Back to top

Customer support and medical information

Prescription medicines/customer support team
Email: customercontact@gsk.com

UK medical and safety information
Tel: +44 (0)800 221 441

Back to top

Media enquiries

UK Commercial
Email: uk.media@gsk.com

Back to top

Reporting an adverse event

We routinely monitor the safety of all our medicines and all adverse events should be reported to us and the Medicines and Healthcare products Regulatory Agency via their yellow card scheme. If you would like to report an adverse event, please use our 

Report a possible Adverse Events form

Back to top

UK Human Resources Support

Use the UK HR main number to contact the right team for information regarding benefits and employment related questions: 

Email: UKIRL.ServiceHR@gsk.com
Tel: +44 (0)20 7660 6942

 

Back to top

Healthcare professionals

Healthcare professionals (HCPs) in the UK can get information about our products and therapy areas by visiting GSKPro

As a healthcare company we regularly work with HCPs. From collaborating on clinical trials to providing high quality, balanced information about our medicines and vaccines, in all of our interactions we aim to be transparent about our work, operate with integrity, and always put the interests of patients first. 

Disclosure of payments made to HCPs in the UK

In line with EFPIA Disclosure Code, disclosure information in the UK is published annually (covering the previous year) through the Association of the British Pharmaceutical Industry (ABPI) Disclosure UK website. You can find more information on our disclosure of payments here.

Back to top

Partnerships

Despite having some of the best people and research facilities, experience has shown us that we can achieve even more through strong partnerships.

These can be with the NHS, other companies, non-profit organisations and the academic world. In fact, it’s a key element in our business strategy, which helps us develop innovative new medicines and vaccines but also helps improve access to treatments and patient care

Joint working

We are actively involved in a wide number of joint working projects with the NHS throughout the UK. By working together we aim to improve the management of different conditions, introduce greater efficiency introduce greater efficiency and to achieve our ambition to unite science, technology and talent to get ahead of disease together.

The projects outlined below were undertaken over the last five years and, over this period, codes, regulations and laws governing the areas covered by the studies may have changed. When reading the documents please be assured that all projects followed the particular standards in force at the time even though these may have subsequently changed.

All of the featured case studies are intended to give an overview of the individual project including its background, the potential benefits for the patient, the NHS, GSK and any other stakeholders.

 

Executive summary

 

Back to top

Summary of outcomes

Supporting materials

Grants and donations

We recognise a responsibility to support activities in our medical community, whether related to medical education where there is patient need and common scientific interest, professional societies’ initiatives, or assisting healthcare organisations and projects that promote other healthcare goals. In all of our interactions we aim to be transparent about our work, operate with integrity, and always put the interests of patients first. 

Criteria for grants and donations

GSK UK’s Grants and Donations Committee uses the following criteria when assessing applications from Healthcare Organisations and Patient Advocacy Groups:

  1. The grant or donation must be used for an activity with a valid and legitimate purpose that enhances patient care, or benefits the NHS and maintains patient care. Programmes currently within scope for approval include:
  • Patient Advocacy Group initiated Programmes and Core Funding
  • Grants to organisations that support healthcare professionals and related staff to attend Scientific Congresses with decision-making independent of GSK
  •  Public policy and advocacy programs and initiatives, including legal reform and government relations
  1. The activity must be in a GSK disease area of strategic priority: Respiratory, Oncology, Specialty and COVID-19, Vaccines.
  2. Funding must be proportional to the activity and not excessive.
  3. Applications must be from a legitimate, reputable organisation that has the capability and licences to conduct the activity.
  4. The grant must be made in a manner that does not affect the independence of the recipient.
  5. A grant will only extend beyond one year under exceptional circumstances.
  6. A grant will not be given to an individual or be used for personal use.
  7. A grant cannot provide more than 25% of total funding received by a single recipient through GSK grants, except for rare disease or start-up patient groups, which can receive up to 50% of the total funding. Any exception requires additional approval and shall not exceed 50% in any case.

How to apply

Please return your completed request form to gsk.grant-request@gsk.com. We will review qualifying grant requests and may reach out for additional information.

Carbon reduction plan

In accordance with UK Cabinet Office standards, the attachment below is GSK’s Carbon Reduction Plan completed in accordance with PPN 06/21 and associated guidance and reporting standards for Carbon Reduction Plans.

Contractor opportunities & temporary opportunities

We have many opportunities for professionals interested in flexible contingent projects with GSK.

Please click here to register in the UK talent pool and access some of the most cutting-edge and exciting project opportunities. GSK’s Contractor & Agency Worker community and all associated activities are managed by our recruitment partner, TAPFIN, a ManpowerGroup Business

To learn more about our early talent programmes, visit our global Early Talent portal. For early talent programmes in the UK, please explore the pages below. 

 

 

 

 

Back to top

Back to top